These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36704514)

  • 1. The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis.
    Yang B; Xiaping Z
    Front Surg; 2022; 9():1031108. PubMed ID: 36704514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.
    Li H; Gui H; Yuan G; Zheng X; Gao C; Yuan H
    Scand J Clin Lab Invest; 2018 Jul; 78(4):269-274. PubMed ID: 29553861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.
    Su X; Yuan X; Li F; Yang G; Du L; Zhao F; Zhao R; Ou M
    PeerJ; 2023; 11():e16057. PubMed ID: 37744231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between C-reactive protein to albumin ratio and restenosis after femoral popliteal stenting in patients with lower extremity arteriosclerotic obliterans].
    Wang YM; Zhang MQ; Chen ZP; Ji R; Cai J; Qiao T
    Zhonghua Wai Ke Za Zhi; 2023 Dec; 61(12):1058-1064. PubMed ID: 37932141
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study.
    Zhao H; Zhuo T; Hao X; Fan X; Zhao P
    Ann Palliat Med; 2022 Aug; 11(8):2720-2729. PubMed ID: 36064362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans.
    Lian W; Nie H; Yuan Y; Wang K; Chen W; Ding L
    J Invest Surg; 2021 Jul; 34(7):765-770. PubMed ID: 31996054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans.
    Sun J; Deng Q; Wang J; Duan S; Chen H; Zhou H; Zhou Z; Yu F; Guo F; Liu C; Xu S; Song L; Wang Y; Feng H; Yu L
    Front Cardiovasc Med; 2022; 9():853583. PubMed ID: 35445093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.
    Xiao D; Song J
    Comput Math Methods Med; 2022; 2022():9190292. PubMed ID: 35966252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Level of Tim-3
    Cui L; Chen L; Dai Y; Ou J; Qiu M; Wang S
    Front Immunol; 2022; 13():871362. PubMed ID: 35757718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
    Zhao J; Jiao YW; Qian J; Qian ZF; Yang HJ; Tang LM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct; 25(10):913-920. PubMed ID: 36245117
    [No Abstract]   [Full Text] [Related]  

  • 11. CCCTC-binding factor suppresses alpha-2-macroglobulin transcription to improve vascular endothelial cell functions in lower extremity arteriosclerosis obliterans.
    He T; You M; Zhu H; Chen P; Fang S
    Gen Physiol Biophys; 2024 May; 43(3):231-242. PubMed ID: 38774923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease.
    Zhang B; Yao Y; Sun QF; Liu SQ; Jing B; Yuan C; Liu XY; Jiao T; Li HC; Wang HY
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28250135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical significance of HSP27 and its phosphorylation in lower extremity arteriosclerosis obliterans.
    Bai J; Wang F; Wang X; Mutu E; Duan C; Qi Y; Hu L; Gao Z
    PeerJ; 2020; 8():e9305. PubMed ID: 32566403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of high mobility group box 1, von Willebrand factor and other cytokines in the evaluation of severity and prognosis of sepsis patients].
    Chen Y; Huang X; Kong G; Liu X; Tian H; Lyu B; Ning F; Wang T; Hao D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):933-937. PubMed ID: 32912405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanistic care interventions in patients with lower extremity arteriosclerosis obliterans.
    He Y; Xie C; Xia Y; Rang J; Peng L
    Am J Transl Res; 2021; 13(9):10527-10535. PubMed ID: 34650723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alprostadil plus cilostazol on the treatment outcomes and inflammatory factors in patients with lower extremity arteriosclerosis obliterans receiving evidence-based care.
    Liang H; Liu P; Yang M; Di P; Wu W; Li H; Liu Y
    Clin Hemorheol Microcirc; 2024; 87(4):405-413. PubMed ID: 38848169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in serum high mobility group box-1 protein and high-sensitivity C-reactive protein in patients with acute cerebral infarction and their clinical significance].
    Zhou P; Li YQ; Li WD; Han TS; Yang SJ; Yao YM; Zhang YY; Yu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 May; 24(5):265-8. PubMed ID: 22587919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.
    Yu ZH; Wang HT; Tu C
    Eur J Med Res; 2017 Jan; 22(1):2. PubMed ID: 28057086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.
    He W; Xu C; Wang X; Lei J; Qiu Q; Hu Y; Luo D
    BMC Cardiovasc Disord; 2021 Sep; 21(1):435. PubMed ID: 34521385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma heparin cofactor II activity correlates with the incidence of in-stent restenosis after the intervention of arteriosclerosis obliterans in lower extremity].
    Lu H; Guo P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):177-81. PubMed ID: 25769326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.